Tech Company Financing Transactions
Aratana Therapeutics Funding Round
Aratana Therapeutics closed a $12 million Series C investment round on 2/1/2013. Backers included private investors.
Transaction Overview
Company Name
Announced On
2/1/2013
Transaction Type
Venture Equity
Amount
$12,000,000
Round
Series C
Investors
Proceeds Purpose
Proceeds will fund the continued expansion of the company's pipeline of companion animal therapeutic products.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
1901 Olathe Blvd.
Kansas City, KS 66103
USA
Kansas City, KS 66103
USA
Phone
Website
Email Address
Not Recorded
Overview
Aratana Therapeutics develops innovative therapies for the animal health industry.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Steven Peter
Chief Scientific Officer
Linda Rhodes
Browse more venture capital transactions:
Prev: 1/31/2013: Internet Time Machine Project venture capital transaction
Next: 2/1/2013: Connected Data venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs